fezakinumab (101)							9137

Structure	 

Heavy chain / Chaone lourde / Cadena pesada

QVQLVQSGAE VKKPGASVKV SCKASGYTFT NYYMHWVRQA PGQGLEWVGW  50

INPYTGSAFY AQKFRGRVTM TRDTSISTAY MELSRLRSDD TAVYYCAREP 100

EKFDSDDSDV WGRGTLVTVS SASTKGPSVF PLAPSSKSTS GGTAALGCLV 150

KDYFPEPVTV SWNSGALTSG VHTFPAVLQS SGLYSLSSVV TVPSSSLGTQ 200

TYICNVNHKP SNTKVDKKVE PKSCDKTHTC PPCPAPELLG GPSVFLFPPK 250

PKDTLMISRT PEVTCVVVDV SHEDPEVKFN WYVDGVEVHN AKTKPREEQY 300

NSTYRVVSVL TVLHQDWLNG KEYKCKVSNK ALPAPIEKTI SKAKGQPREP 350

QVYTLPPSRE EMTKNQVSLT CLVKGFYPSD IAVEWESNGQ PENNYKTTPP 400

VLDSDGSFFL YSKLTVDKSR WQQGNVFSCS VMHEALHNHY TQKSLSLSPG 450

Light chain / Chaone lygire / Cadena ligera

QAVLTQPPSV SGAPGQRVTI SCTGSSSNIG AGYGVHWYQQ LPGTAPKLLI  50

YGDSNRPSGV PDRFSGSKSG TSASLAITGL QAEDEADYYC QSYDNSLSGY 100

VFGGGTQLTV LGQPKAAPSV TLFPPSSEEL QANKATLVCL ISDFYPGAVT 150

VAWKADSSPV KAGVETTTPS KQSNNKYAAS SYLSLTPEQW KSHRSYSCQV 200

THEGSTVEKT VAPTECS                                     217

Disulfide bridges location / Position des ponts disulfure / Posiciones
de los puentes disulfuro

Intra-H	22-96	148-204	265-325	371-429

	22??-96??	148??-204??	265??-325??	371??-429??

Intra-L	22?-90?	139?-198?



	22???-90???	139???-198???



Inter-H-L	224-216?	224??-216???



Inter-H-H	230-230??	233-233??





N-glycosylation sites / Sites de N-glycosylation / Posiciones de
N-glicosilaciun

301, 301??

CAS		1007106-86-6

Description

immunoglobulin G1-lambda, anti-[Homo sapiens interleukin 22 (IL22,
IL-22, ILTIF, IL-TIF)], Homo sapiens monoclonal antibody; 

gamma1 heavy chain (1-450) [Homo sapiens VH (IGHV1-2*02 (91.80%)
-(IGHD)-IGHJ2*01) [8.8.14] (1-121) -IGHG1*03 CH1 R120>K, CH3 K130>del
(122-450)], (224-216?)-disulfide with lambda light chain (1?-217?) [Homo
sapiens V-LAMBDA (IGLV1-40*01 (96.00%) -IGLJ2*01 K123>Q) [9.3.11]
(1?-111?) -IGLC2*01 (112?-217?)]; (230-230??:233-233??)-bisdisulfide
dimer 

immunoglobuline G1-lambda, anti-[Homo sapiens interleukine 22 (IL22,
IL-22, ILTIF, IL-TIF)], Homo sapiens anticorps monoclonal; 

chaone lourde gamma1 (1-450) [Homo sapiens VH (IGHV1-2*02 (91.80%)
-(IGHD)-IGHJ2*01) [8.8.14] (1-121) -IGHG1*03 CH1 R120>K, CH3 K130>del
(122-450)], (224-216?)-disulfure avec la chaone lygire lamba (1?-217?)
[Homo sapiens V-LAMBDA (IGLV1-40*01 (96.00%) -IGLJ2*01 K123>Q) [9.3.11]
(1?-111?) -IGLC2*01 (112?-217?)]; dimire
(230-230??:233-233??)-bisdisulfure 

inmunoglobulina G1-lambda, anti-[interleukina 22 (IL22, IL-22, ILTIF,
IL-TIF) de Homo sapiens], anticuerpo monoclonal de Homo sapiens; 

cadena pesada gamma1 (1-450) [Homo sapiens VH (IGHV1-2*02 (91.80%)
-(IGHD)-IGHJ2*01) [8.8.14] (1-121) -IGHG1*03 CH1 R120>K, CH3 K130>del
(122-450)], (224-216?)-disulfuro con la cadena ligera lambda (1?-217?)
[Homo sapiens V-LAMBDA (IGLV1-40*01 (96.00%) -IGLJ2*01 K123>Q) [9.3.11]
(1?-111?) -IGLC2*01 (112?-217?)]; dnmero
(230-230??:233-233??)-bisdisulfuro 

	

WHO 

International Nonproprietary Names Programme	

15/07/2009

p. 1/1

		

